Philipp Schreiber is an Associate at ATAI Life Sciences. Beyond supporting ATAI, Philipp is responsible for portfolio development at Apeiron Investment Group, the family office of Christian Angermayer, where he mainly focuses on corporate strategy and deal execution for the groups biotech platform companies. Philipp brings experience in M&A transactions, venture capital and strategic management.
He received his BSc. in Business Law from Erlangen University in Germany and his MSc. in Innovation, Entrepreneurship and Management from Imperial College in the UK.